
Retro
retro.bioDeveloper of cellular reprogramming, autophagy, and plasma-inspired therapeutics designed to increase healthy human lifespan.
LBX PPS
1Y return
$12.00
Last Round
May 2026
Later Stage VC
Later Stage VC · $1.8B
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...
Explore related companies
More company profiles from the LBX Pro directory.